Role of hexokinase-1 in the survival of hiv-1-infected macrophages

Cell Cycle

Volumn 14, Issue 7, 2015, Pages 980-989

  Sen, Satarupa ^a,b   Kaminiski, Rafal ^b   Deshmane, Satish ^b   Langford, Dianne ^b,c   Khalili, Kamel ^a,b,c   Amini, Shohreh ^a,b,c   Datta, Prasun K ^b,c  

^a Temple University   (United States)

^b TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c TEMPLE UNIVERSITY   (United States)

Author keywords

Apoptosis; Glucose metabolism; Hexokinase; HIV 1; Macrophage; Mitochondria

Indexed keywords

CASPASE 3; CASPASE 7; CLOTRIMAZOLE; HEXOKINASE 1; VPR PROTEIN; HEXOKINASE; HK1 PROTEIN, HUMAN;

APOPTOSIS; ARTICLE; CELL MEMBRANE DEPOLARIZATION; CELL SURVIVAL; CONTROLLED STUDY; ENZYME ACTIVITY; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; MACROPHAGE; MITOCHONDRIAL MEMBRANE DEPOLARIZATION; MITOCHONDRION; MONOCYTE; PROTEIN EXPRESSION; ENZYMOLOGY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MITOCHONDRIAL MEMBRANE POTENTIAL; PHYSIOLOGY; PROTEIN TRANSPORT; TUMOR CELL LINE; VIROLOGY;

HUMAN IMMUNODEFICIENCY VIRUS 1;

CELL LINE, TUMOR; CELL SURVIVAL; HEXOKINASE; HIV INFECTIONS; HIV-1; HUMANS; MACROPHAGES; MEMBRANE POTENTIAL, MITOCHONDRIAL; MITOCHONDRIA; MONOCYTES; PROTEIN TRANSPORT;

EID: 84928154915     PISSN: 15384101     EISSN: 15514005     Source Type: Journal    
DOI: 10.1080/15384101.2015.1006971     Document Type: Article

References (50)

1. Locati M, Mantovani A, Sica A. Macrophage activation and polarization as an adaptive component of innate immunity. Adv Immunol. 2013; 120:163-84; PMID:24070384; http://dx.doi.org/10.1016/B978-0- 12-417028-5.00006-5
2. Koenig S, Gendelman HE, Orenstein JM, Dal Canto MC, Pezeshkpour GH, Yungbluth M, Janotta F, Aksamit A, Martin MA, Fauci AS. Detection of AIDS virus in macrophages in brain tissue from AIDS patients with encephalopathy. Science. 1986; 233:1089-93; PMID:3016903; http://dx.doi.org/10.1126/science. 3016903
3. Cosenza MA, Zhao ML, Lee SC. HIV-1 expression protects macrophages and microglia from apoptotic death. Neuropathol Appl Neurobiol. 2004; 30:478-90; PMID:15488024; http://dx.doi.org/10.1111/j.1365- 2990.2004.00563.x
4. Swingler S, Mann AM, Zhou J, Swingler C, Stevenson M. Apoptotic killing of HIV-1-infected macrophages is subverted by the viral envelope glycoprotein. PLoS Pathog. 2007; 3:1281-90; PMID:17907802; http://dx. doi.org/10.1371/journal.ppat.0030134
5. Le Douce V, Herbein G, Rohr O, Schwartz C. Molecular mechanisms of HIV-1 persistence in the monocytemacrophage lineage. Retrovirology. 2010; 7:32; PMID:20380694; http://dx.doi.org/10.1186/1742- 4690-7-32
6. Busca A, Saxena M, Kumar A. Critical role for antiapoptotic Bcl-xL and Mcl-1 in human macrophage survival and cellular IAP1/2 (cIAP1/2) in resistance to HIV-Vpr-induced apoptosis. J Biol Chem. 2012; 287:15118-133; PMID:22403404; http://dx.doi.org/ 10.1074/jbc.M111.312660
7. Desplats P, Dumaop W, Smith D, Adame A, Everall I, Letendre S, Ellis R, Cherner M, Grant I, Masliah E. Molecular and pathologic insights from latent HIV-1 infection in the human brain. Neurology. 2013; 80:1415-23; PMID:23486877; http://dx.doi.org/ 10.1212/WNL.0b013e31828c2e9e
8. Lamers SL, Fogel GB, Nolan DJ, McGrath MS, Salemi M. HIV-associated neuropathogenesis: a systems biology perspective for modeling and therapy. Biosystems. 2014; 119:53-61; PMID:24732754; http://dx.doi.org/ 10.1016/j.biosystems.2014.04.002
9. Dahiya S, Irish BP, Nonnemacher MR, Wigdahl B. Genetic variation and HIV-associated neurologic disease. Adv Virus Res. 2013; 87:183-240; PMID:23809924; http://dx.doi.org/10.1016/B978-0- 12-407698-3.00006-5
10. Barrero CA, Datta PK, Sen S, Deshmane S, Amini S, Khalili K, Merali S. HIV-1 Vpr modulates macrophage metabolic pathways: a SILAC-based quantitative analysis. PLoS One. 2013;8:e68376; PMID:23874603; http://dx.doi.org/10.1371/journal.pone.0068376
11. Wilson JE. Isozymes of mammalian hexokinase: structure, subcellular localization and metabolic function. J Exp Biol. 2003; 206:2049-57; PMID:12756287; http://dx.doi.org/10.1242/jeb.00241
12. Xie GC, Wilson JE. Rat brain hexokinase: the hydrophobic N-terminus of the mitochondrially bound enzyme is inserted in the lipid bilayer. Arch Biochem Biophys 1988; 267:803-10; PMID:3214181; http:// dx.doi.org/10.1016/0003-9861(88)90090-2
13. Sui D, Wilson JE. Structural determinants for the intracellular localization of the isozymes of mammalian hexokinase: intracellular localization of fusion constructs incorporating structural elements from the hexokinase isozymes and the green fluorescent protein. Arch Biochem Biophys 1997; 345:111-25; PMID:9281318; http://dx.doi.org/10.1006/abbi.1997.0241
14. Halestrap AP, McStay GP, Clarke SJ. The permeability transition pore complex: another view. Biochimie. 2002; 84:153-166; PMID:12022946; http://dx.doi. org/10.1016/S0300-9084(02)01375-5
15. Pastorino JG, Shulga N, Hoek JB. Mitochondrial binding of hexokinase II inhibits Bax-induced cytochrome c release and apoptosis. J Biol Chem. 2002; 277:7610-18; PMID:11751859; http://dx.doi.org/ 10.1074/jbc.M109950200
16. Azoulay-Zohar H, Israelson A, Abu-Hamad S, Shoshan-Barmatz V. In self-defence: hexokinase promotes voltage-dependent anion channel closure and prevents mitochondriamediated apoptotic cell death. Biochem J 2004; 377:347-55; PMID:14561215; http://dx.doi.org/10.1042/BJ20031465
17. Cassol E, Alfano M, Biswas P, Poli G. Monocytederived macrophages and myeloid cell lines as targets of HIV-1 replication and persistence. J Leukoc Biol. 2006; 80:1018-30; PMID:16946020; http://dx.doi. org/10.1189/jlb.0306150
18. Folks TM, Justement J, Kinter A, Dinarello CA, Fauci AS. Cytokine-induced expression of HIV-1 in a chronically infected promonocyte cell line. Science 1987; 238:800-02; PMID:3313729; http://dx.doi.org/ 10.1126/science.3313729
19. Bristow CL, Wolkowicz R, Trucy M, Franklin A, Di Meo F, Kozlowski MT, Winston R, Arnold RR. NF-kappaB signaling, elastase localization, and phagocytosis differ in HIV-1 permissive and nonpermissive U937 clones. J Immunol. 2008; 180:492-99; PMID:18097051; http://dx.doi.org/ 10.4049/jimmunol.180.1.492
20. Fernandez Larrosa PN, Croci DO, Riva DA, Bibini M, Luzzi R, Saracco M, Mersich SE, Rabinovich GA, Martinez Peralta L. Apoptosis resistance in HIV-1 persistently- infected cells is independent of active viral replication and involves modulation of the apoptotic mitochondrial pathway. Retrovirology. 2008; 5:19; PMID:18261236; http://dx.doi.org/10.1186/1742- 4690-5-19
21. Olivares I, Ballester A, Lombardia L, Dominguez O, Lopez-Galindez C. Human immunodeficiency virus type 1 chronic infection is associated with different gene expression in MT-4, H9 and U937 cell lines. Virus Res. 2009; 139:22-31; PMID:19000723; http:// dx.doi.org/10.1016/j.virusres.2008.09.010
22. Majewski N, Nogueira V, Bhaskar P, Coy PE, Skeen JE, Gottlob K, Chandel NS, Thompson CB, Robey RB, Hay N. Hexokinase-mitochondria interaction mediated by Akt is required to inhibit apoptosis in the presence or absence of Bax and Bak. Mol Cell. 2004; 16:819-30; PMID:15574336; http://dx.doi.org/ 10.1016/j.molcel.2004.11.014
23. Sun L, Shukair S, Naik TJ, Moazed F, Ardehali H (2008) Glucose phosphorylation and mitochondrial binding are required for the protective effects of hexokinases I and II. Mol Cell Biol. 2008; 28:1007-17; PMID:18039843; http://dx.doi.org/10.1128/MCB. 00224-07
24. Wu R, Wyatt E, Chawla K, Tran M, Ghanefar M, Laakso M, Epting CL, Ardehali H. Hexokinase II knockdown results in exaggerated cardiac hypertrophy via increased ROS production. EMBO Mol Med. 2012; 4:633-46; PMID:22517678; http://dx.doi.org/ 10.1002/emmm.201200240
25. Connor RI, Chen BK, Choe S, Landau NR (1995) Vpr is required for efficient replication of human immunodeficiency virus type-1 in mononuclear phagocytes. Virology 1995 206:935-44; PMID:7531918; http:// dx.doi.org/10.1006/viro.1995.1016
26. Chiara F, Castellaro D, Marin O, Petronilli V, Brusilow WS, Juhaszova M, Sollott SJ, Forte M, Bernardi P, Rasola A. Hexokinase II detachment from mitochondria triggers apoptosis through the permeability transition pore independent of voltage-dependent anion channels. PLoS One. 2008 19;3(3):e1852; PMID:18350175; http://dx.doi.org/10.1371/journal. pone.0001852
27. Robey RB, Hay N. Mitochondrial hexokinases, novel mediators of the antiapoptotic effects of growth factors and Akt. Oncogene 2005; 25:4683-96; http://dx.doi. org/10.1038/sj.onc.1209595
28. Nicholson DW, Thornberry NA. Caspases: Killer proteases. Trends Biochem. Sci. 1997; 22:299-306; PMID:9270303; http://dx.doi.org/10.1016/S0968- 0004(97)01085-2
29. Thornberry NA, Lazebnik Y. Caspases: Enemies within. Science 1998; 281:1312-16; PMID:9721091; http://dx.doi.org/10.1126/science.281.5381.1312
30. Pinti M, Biswas P, Troiano L, Nasi M, Ferraresi R, Mussini C, Vecchiet J, Esposito R, Paganelli R, Cossarizza A. Different sensitivity to apoptosis in cells of monocytic or lymphocytic origin chronically infected with human immunodeficiency virus type- 1. Experimental Biology and Medicine. 2003; 228:1346-54; PMID:14681550
31. Lum JJ, Badley AD. Resistance to apoptosis. Mechanism for the development of HIV reservoirs. Curr. HIV Res. 2003; 1:261-74; PMID:15046251; http:// dx.doi.org/10.2174/1570162033485203
32. Kumar A, Abbas W, Herbein G. HIV-1 latency in monocytes/macrophages. Viruses. 2014; 6:1837-60; PMID:24759213; http://dx.doi.org/10.3390/ v6041837
33. Badley AD, McElhinny JA, Leibson PJ, Lynch DH, Alderson MR, Paya CV. Up-regulation of Fas ligand expression by human immunodeficiency virus in human macrophages mediates apoptosis of uninfected T lymphocytes. J. Virol. 1996; 70:199-206; PMID:8523526
34. Kiener PA, Davis PM, Starling GC, Mehlin C, Klebanoff SJ, Ledbetter JA, Liles WC. (1997) Differential induction of apoptosis by Fas-Fas ligand interactions in human monocytes and macrophages. J. Exp. Med. 1997; 185:1511-16; PMID:9126933; http://dx.doi. org/10.1084/jem.185.8.1511
35. Guillemard E, Jacquemot C, Aillet F, Schmitt N, Barré-Sinoussi F, Israël N. (2004) Human immunodeficiency virus 1 favors the persistence of infection by activating macrophages through TNF. Virology 2004; 329:371-80; PMID:15518816; http://dx.doi.org/ 10.1016/j.virol.2004.08.030
36. Zhang M, Li X, Pang X, Ding L, Wood O, Clouse KA, Hewlett I, Dayton AI. Bcl-2 upregulation by HIV-1 Tat during infection of primary human macrophages in culture. J. Biomed. Sci. 2002; 9:133-39; PMID:11914580; http://dx.doi.org/10.1007/ BF02256024
37. Olivetta E, Federico M. HIV-1 Nef protects human monocyte-derived macrophages from HIV1-induced apoptosis. Exp. Cell Res. 2006; 312:890-900; PMID:16445909; http://dx.doi.org/10.1016/j. yexcr.2005.12.003
38. Abbas W, Khan KA, Kumar A, Tripathy MK, Dichamp I, Keita M, Mahlknecht U, Rohr O, Herbein G. Blockade of BFA-mediated apoptosis in macrophages by the HIV-1 Nef protein. Cell Death Dis. 2014; 5:e1080; PMID:24556695; http://dx.doi.org/ 10.1038/cddis.2014.16
39. Lucas A, Kim Y, Rivera-Pabon O, Chae S, Kim DH, Kim B. Targeting the PI3K/Akt cell survival pathway to induce cell death of HIV-1 infected macrophages with alkylphospholipid compounds. PLoS One. 2010; 5:e13121; PMID:20927348; http://dx.doi.org/ 10.1371/journal.pone.0013121
40. Tanaka Y, Kameoka M, Ota K, Itaya A, Ikuta K, Yoshihara K. Establishment of persistent infection with HIV- 1 abrogates the caspase-3-dependent apoptotic signaling pathway in U937 cells. Experimental cell research. 1999; 247:514-24; PMID:10066379; http://dx.doi. org/10.1006/excr.1998.4376
41. King A, Gottlieb E. Glucose metabolism and programmed cell death: an evolutionary and mechanistic perspective. Curr Opin Cell Biol. 2009; 21:885-93; PMID:19850457; http://dx.doi.org/10.1016/j. ceb.2009.09.009
42. Hollenbaugh JA, Munger J, Kim B. Metabolite profiles of human immunodeficiency virus infected CD4C T cells and macrophages using LC-MS/MS analysis. Virology. 2011; 415:153-59; PMID:21565377; http:// dx.doi.org/10.1016/j.virol.2011.04.007
43. Linden M, Gellerfors P, Nelson BD. Pore protein and the hexokinase-binding protein from the outer membrane of rat liver mitochondria are identical. FEBS Lett. 1982; 141:189-92; PMID:6178620; http://dx. doi.org/10.1016/0014-5793(82)80044-6
44. Vyssokikh, MY, Brdiczka D. The function of complexes between the outer mitochondrial membrane pore (VDAC) and the adenine nucleotide translocase in regulation of energy metabolism and apoptosis. Acta Biochim. Pol 2003; 50:389-404; PMID:12833165
45. Pennington KN, Taylor JA, Bren GD, Paya CV. IkappaB kinase dependent chronicactivation of NF-kappaB is necessary for p21(WAF1/Cip1) inhibition of differentiation-induced apoptosis of monocytes. Mol Cell Biol. 2001; 21:1930-41; PMID:11238929; http://dx. doi.org/10.1128/MCB.21.6.1930-1941.2001
46. Pastorino JG, Hoek JB. Regulation of hexokinase binding to VDAC. J Bioenerg Biomembr. 2008; 40:171-82; PMID:18683036; http://dx.doi.org/10.1007/ s10863-008-9148-8
47. John S, Weiss JN, Ribalet B. Subcellular localization of hexokinases I and II directs the metabolic fate of glucose. PLoS One 2011; 6:e17674; PMID:21408025; http://dx.doi.org/10.1371/journal.pone.0017674
48. Cheng-Mayer C, Levy JA. Distinct biological and serological properties of human.immunodeficiency viruses from the brain. Ann Neurol. 1988; 23:S58-S61; PMID:3258140.
49. Ahmad A, Ahmad S, Schneider BK, Allen CB, Chang LY, White CW. Elevated expression of hexokinase II protects human lung epithelial-like A549 cells against oxidative injury. Am. J. Physiol. Lung Cell. Mol. Physiol. 2002; 283:L573-84; PMID:12169577
50. Shroff EH, Snyder CM, Budinger GR, Jain M, Chew TL, Khuon S, Perlman H, Chandel NS. BH3 peptides induce mitochondrial fission and cell death independent of BAX/BAK. PLoS One. 2009; 4:e5646; PMID:19468307; http://dx.doi.org/10.1371/journal. pone.0005646